Lunai Bioworks Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2002
-0.0067 (-3.24%)
Sep 11, 2025, 11:08 AM - Market open
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $46.23 million as of September 11, 2025. Its market cap has decreased by -54.23% in one year.
Market Cap
46.23M
Enterprise Value
53.72M
1-Year Change
-54.23%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since December 11, 2018, Lunai Bioworks's market cap has decreased from $252.00M to $46.23M, a decrease of -81.65%. That is a compound annual growth rate of -22.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 35.60M | -73.17% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
| Dec 11, 2018 | 252.00M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.25B |
| Johnson & Johnson | 426.69B |
| AbbVie | 370.98B |
| UnitedHealth Group | 299.72B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.87B |